By interacting directly with CD28 on non-apoptotic tumor PCs, BM-mDCs downregulate the proteasomal subunit expression in these cells, thereby preventing them from being killed by human leukocyte antigen (HLA) class I-limited CD8+ T cells (40). The gene discussed is CD8A; the disease is neoplasm.